Alopecia areata

European Handbook of Dermatological Treatments, Third Edition

Volumn , Issue , 2015, Pages 45-53

  Böhm, Markus ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Alopecia areata; Aroma oils; Intralesional corticosteroids; Supportive therapy; Topical immunotherapy

Indexed keywords

EID: 84944575818     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-662-45139-7_4     Document Type: Chapter

References (8)

1. Alfani S, Antinone V, Mozzetta A, Di Pietro C, Mazzanti C, et al. Psychological status of patients with alopecia areata. Acta Derm Venereol. 2012;92:304-6.
2. Bilgiç O, Bilgiç A, Bahali K, Bahali AG, Gürkan A, et al. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata. J Eur Acad Dermatol Venereol. 2014;28:1463-8.
3. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;19(366):1515-25.
4. Harries MJ, Sun J, Paus R, King Jr LE. Management of alopecia areata. BMJ. 2010;341:c3671.
5. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists’ guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166:916-26.
6. Ohlmeier MV, Traupe H, Luger TA, Böhm M. Topical immunotherapy immunotherapy with diphenylcyclopropenone of patients with alopecia areata-a large retrospective study on 142 patients with a selfcontrolled design. J Eur Acad Dermatol Venereol. 2012;26:503-7.
7. Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines-part II. National Alopecia Areata Foundation. J Am Acad Dermatol. 2004;51:440-7.
8. Paus R, Bertolini M. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives. J Investig Dermatol Symp Proc. 2013;16:S25-7.